Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [1485]

ESMO GI: International phase III trial shows survival benefit of MM-398 added to standard treatment in post-gemcitabine metastatic pancreatic cancer

ESMO GI: International phase III trial shows survival benefit of MM-398 added to standard treatment in post...

A vaccine may cause pancreatic cancer to respond to immunotherapy

A vaccine may cause pancreatic cancer to respond to immunotherapy

Resurrecting immunity against tumours

Resurrecting immunity against tumours

20 years of the European Institute of Oncology

20 years of the European Institute of Oncology

Potential new therapeutic approach identified for two types of pancreatic cancer

Potential new therapeutic approach identified for two types of pancreatic cancer

Blocking one protein may lead to new treatments for two types of pancreatic cancer

Blocking one protein may lead to new treatments for two types of pancreatic cancer

Will a new blood-based biomarker panel lead to prostate cancer diagnosis before patients show symptoms?

Will a new blood-based biomarker panel lead to prostate cancer diagnosis before patients show symptoms?

Pancreatic cancer predicted to overtake other cancer-related deaths in the USA by 2030

Pancreatic cancer predicted to overtake other cancer-related deaths in the USA by 2030

Could switching off this protein halt the spread of pancreatic cancer?

Could switching off this protein halt the spread of pancreatic cancer?

Pancreatic cancer projected to become second leading cause of cancer-related death in the United States by 2030

Pancreatic cancer projected to become second leading cause of cancer-related death in the United States by 2030

More from ecancer